Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-03-19 | Dr. Vasella is Honorary Chairman and former Chairman and CEO of Novartis AG...American Express Committees: Audit and Compliance (Chair), Nominating and Governance, Risk...2017 compensation of non-management directors: Daniel L. Vasella total $351,294. |
| 2019-03-15 | Daniel L. Vasella, 65 Honorary Chairman and Former Chairman and CEO, Novartis AG Director since 2012 Independent Age 65 American Express Committees Audit and Compliance (Chair) Nominating and Governance Risk 2018 compensation: $384,777 |
| 2020-03-24 | Daniel L. Vasella Director Age 66 Chair of Audit and Compliance Committee 2019 compensation total $393,244 |
| 2021-03-19 | Daniel L. Vasella Honorary Chairman and Former Chairman and CEO, Novartis AG Director since 2012 Independent Age 67 Committee Membership(s) Compensation and Benefits Nominating, Governance and Public Responsibility |
| 2022-03-18 | Daniel L. Vasella Director since 2012 | Independent | Age 68 Committees: Compensation and Benefits | Nominating, Governance and Public Responsibility ... 2021 compensation of non-management directors ... Daniel L. Vasella ... Total $395,347 |
| 2023-03-17 | Dr. Vasella has been an Honorary Chairman of Novartis AG since 2013. Prior to that, Dr. Vasella served as Chairman of Novartis from 1999 to 2013 and as CEO from 1996 to 2010. From 1992 to 1996, Dr. Vasella held the positions of CEO, Chief Operating Officer, Senior Vice President and Head of Worldwide Development and Head of Corporate Marketing at Sandoz Pharma Ltd. Dr. Vasella is a former member of the International Business Leaders Advisory Council for the Mayor of Shanghai, a foreign honorary member of the Academy of Arts and Sciences and a former trustee of the Carnegie Endowment for International Peace. He also serves as a member of the board of directors of PepsiCo, Inc. and SciClone Pharmaceuticals, Inc. Dr. Vasella received his Doctorate of Medicine from the University of Bern in Switzerland and attended Harvard University’s Program for Management Development. 2022 compensation: $435,220. |
| 2024-03-15 | Dr. Vasella brings to the Board his deep experience leading a highly regulated global business as well as a global perspective. Dr. Vasella has been an Honorary Chairman of Novartis AG since 2013. Prior to that, Dr. Vasella served as Chairman of Novartis from 1999 to 2013 and as CEO from 1996 to 2010. From 1992 to 1996, Dr. Vasella held the positions of CEO, Chief Operating Officer, Senior Vice President and Head of Worldwide Development and Head of Corporate Marketing at Sandoz Pharma Ltd. Dr. Vasella is a foreign honorary member of the Academy of Arts and Sciences and a former trustee of the Carnegie Endowment for International Peace. Dr. Vasella is a director, chair of the nominating and corporate governance committee, and a member of the compensation committee at PepsiCo, Inc. He also serves as a director at SciClone Pharmaceuticals, Inc. Dr. Vasella received his Doctorate of Medicine from the University of Bern in Switzerland and attended Harvard University’s Program for Management Development. |
| 2025-03-14 | Dr. Vasella has been an Honorary Chairman of Novartis AG since 2013. |
Data sourced from SEC filings. Last updated: 2025-07-01